SENSEX NIFTY
Jan 07, 2011, 05.05 PM IST | Source: Moneycontrol.com

Elder Pharma in talks with Japanese cos to supply bulk drug

With plans of creeping in share acquisition, promoters of Elder Pharmaceuticals have entered in talks with some Japanese companies to supply bulk drugs. The company would start marketing the products in Japan in the next three to four months.

Elder Pharma in talks with Japanese cos to supply bulk drug

With plans of creeping in share acquisition, promoters of Elder Pharmaceuticals have entered in talks with some Japanese companies to supply bulk drugs. The company would start marketing the products in Japan in the next three to four months.

The pharma major recently received an accreditation from the Ministry of Health, Japan for their API plant in Maharashtra. Talking to CNBC-TV18, director Alok Saxena said that the accreditation would help enter grow in the Japanese pharma market.

Elder Pharma stock price

On October 23, 2014, Elder Pharmaceuticals closed at Rs 178.15, up Rs 1.65, or 0.93 percent. The 52-week high of the share was Rs 349.00 and the 52-week low was Rs 162.00.


The company's trailing 12-month (TTM) EPS was at Rs 7.89 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 22.58. The latest book value of the company is Rs 387.10 per share. At current value, the price-to-book value of the company is 0.46.

READ MORE ON  Elder, Elder Pharmaceuticals
Set email alert for

ADS BY GOOGLE

video of the day

All portents good; optimistic for next few Diwali's: Damani

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.